* Cosmos Health Inc COSM.OQ COSM.O is expected to report
resultson August 9 (estimated) for the period ending March
31 2024
* The Chicago Illinois-based company is expected to report
revenue of $14.55 million, according to the estimate from one
analyst, based on LSEG data.
* LSEG's mean analyst estimate for Cosmos Health Inc is for
a
loss of 14 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cosmos
Health Inc
is $4.00, above its last closing price of $1.12.
This summary was machine generated August 9 at 18:35 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)